Detalhe da pesquisa
1.
T cells become licensed in the lung to enter the central nervous system.
Nature
; 488(7413): 675-9, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22914092
2.
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
J Immunol
; 187(1): 55-63, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21613613
3.
An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma.
Int J Cancer
; 128(4): 897-907, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20473889
4.
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy.
Eur J Immunol
; 32(11): 3235-45, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12555669
5.
Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.
J Immunol
; 169(7): 3892-9, 2002 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12244187